Skip to content
healthcare.dev

Glipizide

NDC 70518-3898, Glipizide, tablet, extended release, from REMEDYREPACK INC..

Product NDC
70518-3898
Status
Listed
Labeler
REMEDYREPACK INC.
Dosage form
TABLET, EXTENDED RELEASE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA206928
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/70518-3898 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • GLIPIZIDE5 mg/1

Pharmacologic classes

Sulfonylurea Compounds [CS]; Sulfonylurea [EPC]

Package NDCNDC-11Package
70518-3898-07051838980090 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (70518-3898-0)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/0df8f606-97b3-463c-a132-338cf4630a71

Use it

Look up 70518-3898 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/70518-3898 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 70518-3898. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.